FULGENT GENETICS, INC. (FLGT) Operating cash flow 2016–2025
FULGENT GENETICS, INC. (FLGT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$101.6MFY2025 · since FY2016: $4.4M → -$101.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$101.6M | -582.6% |
| FY2024 | $21.1M | -22.0% |
| FY2023 | $27.0M | -89.3% |
| FY2022 | $253.5M | -52.9% |
| FY2021 | $538.6M | +283.0% |
| FY2020 | $140.6M | +2449.0% |
| FY2019 | $5.5M | +917.3% |
| FY2018 | -$675,000 | -150.7% |
| FY2017 | $1.3M | -69.8% |
| FY2016 | $4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FLGT financial trends
FLGT RevenueFLGT Net incomeFLGT Net marginFLGT Gross profitFLGT Gross marginFLGT Operating incomeFLGT Operating marginFLGT Free cash flowFLGT Capital expendituresFLGT Return on equityFLGT Stock buybacksFLGT Dividends paidFLGT Total assetsFLGT Total liabilitiesFLGT Shareholders’ equityFLGT overview →